James CM - Search Results

1

Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.

James CM, Abdad MY, Mansfield JP, Jacobsen HK, Vind AR, Stumbles PA, Bartlett EJ. James CM, et al. Vaccine. 2007 Feb 26;25(10):1856-67. doi: 10.1016/j.vaccine.2006.10.038. Epub 2006 Nov 3. Vaccine. 2007. PMID: 17240000

2

Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry.

James CM, Foong YY, Mansfield JP, Fenwick SG, Ellis TM. James CM, et al. Vaccine. 2007 Aug 1;25(31):5892-901. doi: 10.1016/j.vaccine.2007.05.023. Epub 2007 Jun 4. Vaccine. 2007. PMID: 17583393

3

Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance.

James CM, Foong YY, Mansfield JP, Vind AR, Fenwick SG, Ellis TM. James CM, et al. Vaccine. 2008 Oct 3;26(42):5345-51. doi: 10.1016/j.vaccine.2008.08.008. Epub 2008 Aug 22. Vaccine. 2008. PMID: 18723069

4

Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice.

Cull VS, Broomfield S, Bartlett EJ, Brekalo NL, James CM. Cull VS, et al. Among authors: james cm. Gene Ther. 2002 Oct;9(20):1369-78. doi: 10.1038/sj.gt.3301809. Gene Ther. 2002. PMID: 12365002

5

Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.

Cull VS, Bartlett EJ, James CM. Cull VS, et al. Among authors: james cm. Immunology. 2002 Jul;106(3):428-37. doi: 10.1046/j.1365-2567.2002.01423.x. Immunology. 2002. PMID: 12100732 Free PMC article.

6

Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.

Bartlett EJ, Cull VS, Brekalo NL, Lenzo JC, James CM. Bartlett EJ, et al. Among authors: james cm. Immunol Cell Biol. 2002 Oct;80(5):425-35. doi: 10.1046/j.1440-1711.2002.01103.x. Immunol Cell Biol. 2002. PMID: 12225378

7

Type I interferon differential therapy for erythroleukemia: specificity of STAT activation.

Cull VS, Tilbrook PA, Bartlett EJ, Brekalo NL, James CM. Cull VS, et al. Among authors: james cm. Blood. 2003 Apr 1;101(7):2727-35. doi: 10.1182/blood-2002-05-1521. Epub 2002 Nov 21. Blood. 2003. PMID: 12446459 Free article.

8

Optimization of Naked DNA Delivery for Interferon Subtype Immunotherapy in Cytomegalovirus Infection.

Bartlett EJ, Cull VS, Mowe EN, Mansfield JP, James CM. Bartlett EJ, et al. Among authors: james cm. Biol Proced Online. 2003;5:43-52. doi: 10.1251/bpo45. Epub 2003 Feb 17. Biol Proced Online. 2003. PMID: 12734557 Free PMC article.

9

Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-alpha therapy.

Lenzo JC, Mansfield JP, Sivamoorthy S, Cull VS, James CM. Lenzo JC, et al. Among authors: james cm. Cell Immunol. 2003 May;223(1):77-86. doi: 10.1016/s0008-8749(03)00150-3. Cell Immunol. 2003. PMID: 12914761

10

Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis.

Bartlett EJ, Lenzo JC, Sivamoorthy S, Mansfield JP, Cull VS, James CM. Bartlett EJ, et al. Among authors: james cm. Immunol Cell Biol. 2004 Apr;82(2):119-26. doi: 10.1046/j.0818-9641.2004.01234.x. Immunol Cell Biol. 2004. PMID: 15061762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters